Ampersand Capital Partners Is A Middle Market Private Equity Firm Established In 1988Based In Bostonmawith An Additional Office In Amsterdamnetherlandsthe Firm Focuses On Growth Oriented Investments In The Healthcare Sectormanaging Approximately $3 Billion In Assets As Of 2023Ampersand Is Recognized For Its Significant Role In The Life Sciences Investment Landscape The Firm Specializes In Equity Investments Within The Life Sciences Ecosystemincluding Laboratory Productslab Servicescontract Manufacturingpharma Servicesand Specialty Pharmaampersand Employs A Collaborative Investment Approachworking Closely With Portfolio Company Founders And Leadership Teams To Drive Growth And Enhance Valuetheir Portfolio Consists Of Over 80 Companies That Provide Essential Tools And Services To Life Sciences Innovatorssupporting Various Aspects Of Pharmaceutical Development And Manufacturing
